The biotechnology company posted revenue of $170.2 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected ...
News
- Seattle Genetics: 2Q Earnings Snapshot
- Amgen: 2Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $6.06 billion in the period, also exceeding Street forecasts. Eight analysts surveyed by Zacks ...
- Why Are Only 4 Percent of Cannabis Businesses Owned By African Americans?
Take Shanel Lindsay, the founder of Ardent Cannabis, a Boston-based biotech and medical cannabis company that specializes in the development of ...
- Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ...
SAN DIEGO, July 26, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology ...
- Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ...
About Halozyme Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that ...